Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.60692/a0srn-8es20
Publication URI: https://gresis.osc.int//doi/10.60692/a0srn-8es20
Type: Other